Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

19 Press Releases
DateTitleCompany
16 Aug 12 Tonix Pharmaceuticals CEO Dr. Seth Lederman Describes Potential Treatment for Fibromyalgia, Post-Traumatic Stress Disorder and Traumatic Brain Injury Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
14 Aug 12 Tonix Pharmaceuticals Reports That Sublingual Formulation of Fibromyalgia Drug Reduces Production of a Psychoactive Metabolite, Improving Suitability for Long-Term, Chronic Treatment Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
30 Jul 12 Tonix Pharmaceuticals Announces Completion of Clinical Trial of Sublingual TNX-102 Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
09 Jul 12 Tonix Pharmaceuticals Reports Positive Preclinical Data on Sublingual TNX-102 Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
27 Jun 12 Tonix Pharmaceuticals to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28 Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
27 Jun 12 Tonix Pharmaceuticals Receives Health Canada Clearance to Study a Novel Treatment for Fibromyalgia Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
19 Jun 12 Tonix Pharmaceuticals to Present at Marcum MicroCap Conference Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
14 Jun 12 Tonix Pharmaceuticals Featured on GLX-TV OpenCEOLive Series Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
23 May 12 Tonix Pharmaceuticals CEO Interviewed on CEOLive.TV Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
11 May 12 CORRECTING and REPLACING Tonix Pharmaceuticals Appoints Dr. Samuel Saks to Its Board of Directors Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
10 May 12 Tonix Pharmaceuticals Appoints Dr. Samuel Saks to Its Board of Directors Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
06 Apr 12 TONIX Pharmaceuticals Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia TONIX Pharmaceuticals Holding Corp.,
Published by
Business Wire
04 Apr 12 TONIX Pharmaceuticals Strengthens Management Team with the Appointments of Its New Chief Financial Officer and Senior Director of Drug Development Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
15 Mar 12 TONIX Pharmaceuticals Holding Corp. Closes on Net Proceeds of $2.0 Million in Second Tranche of a $6.6 Million Private Placement Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
07 Feb 12 TONIX Pharmaceuticals to Present at the 14th Annual Bio CEO & Investor Conference on February 14, 2012 Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
23 Jan 12 TONIX Pharmaceuticals Closes $4.3 Million Private Placement TONIX Pharmaceuticals Holding Corp.,
Published by
Business Wire
04 Jan 12 Tonix Pharmaceuticals to Present at Biotech Showcase and OneMedForum Conferences in San Francisco on January 9 and 10, 2012 Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
18 Nov 11 Tonix Pharmaceuticals Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 For Fibromyalgia Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
20 Oct 11 Tamandare Explorations Inc. Announces Name Change to Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals Holding Corp.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.